ZEN Graphene Solutions, formerly called Zenyatta Ventures, is a mineral exploration and development company based in Ontario, Canada. Zen is developing the Albany Graphite Deposit – a rare hydrothermal graphite deposit with the potential to produce a natural, high-purity graphite that may compete in high-technology markets traditionally reserved for synthetic graphite.
The company's high crystallinity graphite can be upgraded without the use of aggressive acid (HF) or high temperature thermal treatment. Zen has developed an environmentally friendly metallurgical process flowsheet that consists of grinding, flotation and caustic treatment using sodium hydroxide. The company states that it has been able to achieve an extraordinary carbon purity result of >99.9 percent in bench-scale tests, using this proprietary and environmentally friendly purification process.
According to the Zen, current end uses for its graphene materials include composites (concrete, rubber and plastics), energy storage and environmental applications but many more are under development.
The latest ZEN Graphene news:
Zen Graphene Solutions and Graphene Composites collaborate on graphene ink on fabrics for Coronavirus protection
ZEN Graphene Solutions has announced an international collaboration with UK-based Graphene Composites to fight COVID-19 by developing a potential virucidal graphene-based composite ink that can be applied to fabrics including N95 face masks and other personal protective equipment (PPE) for significantly increased protection. Once the development, testing, and confirmation of the graphene ink's virucidal ability have been completed, the ink will then be incorporated into fabrics used for PPE.
Francis Dubé, CEO of ZEN commented, "We are pleased to be collaborating with GC and be on the forefront of a new innovative technology that could contribute to combating the deadly COVID-19 virus. The development of this potential COVID-19 virucidal graphene ink is coming at a crucial time to provide effective PPE supplies for the safety of frontline workers and hospital staff." Dr. Dubé continued, "The current N95 masks trap the virus but don't kill it. Our testing will demonstrate if the graphene ink is an effective virucide which would kill the virus as this could make a big difference to people's safety. We have been very impressed by the Graphene Composites team and look forward to continued collaborations."
ZEN Graphene Solutions has commenced scale-up and engineering studies on processes for the production of its Albany Pure Graphene products at the Company’s research and development facility in Guelph, Ontario, Canada.
The priority is to increase graphene production in anticipation of future demand as the Company launched graphene product sales in early March 2020. ZEN will also commission the recently purchased purification autoclave to commence the production of high-purity Albany graphene precursor material.
ZEN Graphene Solutions has announced that it plans to open its new pilot plant and research and development facility in Guelph, Canada on March 3, 2020.
Zen states that when the graphite purification pilot plant becomes operational, it will be capable of producing 99.8% high-purity graphite from the 86% flotation concentrate.
ZEN Graphene Solutions recently shared several updates. The first is that Zen has closed its recent private placement of flow-through common shares of the company and reports that it was oversubscribed. The company raised CAD$1.21 million (around USD$920,300) in respect of the offering, which will be used to finance the 2020 environmental baseline field program and community engagement work on the company's Albany graphite project.
In addition, the Company announced that it is moving forward with graphene production and anticipates that small-scale graphene related production will commence before the end of Q1 2020. The first batch of equipment for the purification small-scale pilot plant was already delivered. In the coming months, ZEN is aiming to setup small-scale graphite purification and graphene-related production facilities including Graphene Quantum Dots (GQDs) and Graphene Oxide (GO). These products will be available for research and development, application development and for commercial use.
ZEN Graphene Solutions signs agreement with Chemisar Laboratories for consulting and new graphene development center
ZEN Graphene Solutions has signed an agreement with Chemisar Laboratories to provide various consulting services which will include the use of 2,300 square feet of office and laboratory space in Guelph, Ontario starting October 1, 2019. This office will become the company’s new graphene research and development center which will include a small-scale graphene processing and production facility. Additional space is available in the building which will allow ZEN to grow as needed.
In the coming months, ZEN is aiming to setup small-scale graphite purification and graphene-related production facilities including Graphene Quantum Dots (GQD’s) and Graphene Oxide (GO). These products will be available for research and development, application development and for commercial use.